The Lancet regional health. Southeast Asia
Beyond immunogenicity in XBB.1.5 subunit COVID-19 boosters focusing on durability, dosing, and target populations: authors reply.
Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, Rammohan Reddy Mogulla, Vijay Yerroju, Siddalingaiah Ningaiah, Mallikarjuna Panchakshari, Chirag Dhar
Published: 202510.1016/j.lansea.2025.100678
No abstract available for this study.